Category: Health & Medicines > Medicines > Beta Glucan
Country/Region: United States State/Province: New Jersey
Main Products: Insulin
Business Type: Exporter, Retailer
Year Established: 2010
Employees: 5 - 10 People
Plant Area: Below 1000 sqm
Main Markets: South America 8% Africa 11% Eastern Asia 9% Domestic Market 11% North America 9% Eastern Europe 10% Southern Europe 8% Mid East 9% Northern Europe 8% Oceania 17%
Trade Capacity: FOB, CFR, CPT
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Newark
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: Above US$100 Million
Export Revenue: US$1 Million - US$2.5 Million
Annual Output: US$1 Million - US$2.5 Million
Registered Capital: US$50 Million - US$100 Million
Export Percentage: 61% - 70%
Payment Modes: USD, EUR, HKD
Lead Time: 17 days
Import/Export Mode: Professional Association